OraSure Technologies | OSUR - Current Assets


OraSure Technologies reported $261.91M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agilent USD 4.62B 21M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Cerus USD 167.13M 1.41M Sep/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.02B 49M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Illumina USD 3.29B 493M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 332.6M 12.2M Dec/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Quidel USD 1.45B 80.6M Dec/2025
Repligen USD 1.14B 40.9M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
STAAR Surgical USD 311.54M 9.66M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025
Waters USD 1.99B 69.86M Dec/2025